Concepedia

David Demedts

DD

Statistics

Publications

9

Citations

497

H-Index

9

Active since

2009

Affiliations

KU Leuven(Current)

Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103

VIB-KU Leuven Center for Cancer Biology

David Demedts is an author at KU Leuven specializing in life sciences, neurodegenerative diseases, and molecular neuroscience.

ORCID

Publications per year

2009–2021

9

Publications

9

Amyloid precursor protein mutation E682K at the alternative β‐secretase cleavage β′‐site increases Aβ generation†

Lujia Zhou, Nathalie Brouwers, Iryna Benilova et al. · EMBO Molecular Medicine · 2011 · 118 citations · Full text

, , +17

Dendritic Degeneration, Neurovascular Defects, and Inflammation Precede Neuronal Loss in a Mouse Model for Tau-Mediated Neurodegeneration

Tomasz Jaworski, Benoit Lechat, David Demedts et al. · American Journal Of Pathology · 2011 · 116 citations · Full text

, , +17

AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice

Tomasz Jaworski, Ilse Dewachter, Benoit Lechat et al. · PLoS ONE · 2009 · 88 citations · Full text

, , +17

Early Improved and Late Defective Cognition Is Reflected by Dendritic Spines in Tau.P301L Mice

Hervé Maurin, David Demedts, Herman Devijver et al. · Journal of Neuroscience · 2011 · 49 citations · Full text

, , +17

Identification of Glycogen Synthase Kinase-3 Inhibitors with a Selective Sting for Glycogen Synthase Kinase-3α

Fabio Lo Monte, Thomas Krämer, Jiamin Gu et al. · Journal of Medicinal Chemistry · 2012 · 44 citations · Full text

, , +9

1–5 of 9